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IMPORTANCE Many patients with acute low back pain do not recover with basic first-line care
(advice, reassurance, and simple analgesia, if necessary). It is unclear whether intensive
patient education improves clinical outcomes for those patients already receiving first-line
care.
OBJECTIVE To determine the effectiveness of intensive patient education for patients with
acute low back pain.
DESIGN, SETTING, AND PARTICIPANTS This randomized, placebo-controlled clinical trial
recruited patients from general practices, physiotherapy clinics, and a research center in
Sydney, Australia, between September 10, 2013, and December 2, 2015. Trial follow-up was
completed in December 17, 2016. Primary care practitioners invited 618 patients presenting
with acute low back pain to participate. Researchers excluded 416 potential participants. All
of the 202 eligible participants had low back pain of fewer than 6 weeks’ duration and a high
risk of developing chronic low back pain according to Predicting the Inception of Chronic Pain
(PICKUP) Tool, a validated prognostic model. Participants were randomized in a 1:1 ratio to
either patient education or placebo patient education.
INTERVENTIONS All participants received recommended first-line care for acute low back pain
from their usual practitioner. Participants received additional 2 × 1-hour sessions of patient
education (information on pain and biopsychosocial contributors plus self-management
techniques, such as remaining active and pacing) or placebo patient education (active
listening, without information or advice).
MAIN OUTCOMES ANDMEASURES The primary outcomewas pain intensity (11-point numeric
rating scale) at 3 months. Secondary outcomes included disability (24-point RolandMorris
Disability Questionnaire) at 1 week, and at 3, 6, and 12 months.
RESULTS Of 202 participants randomized for the trial, the mean (SD) age of participants was
45 (14.5) years and 103 (51.0%) were female. Retention rates were greater than 90% at all
time points. Intensive patient education was not more effective than placebo patient
education at reducing pain intensity (3-monthmean [SD] pain intensity: 2.1 [2.4] vs 2.4 [2.2];
mean difference at 3 months, –0.3 [95% CI, –1.0 to 0.3]). There was a small effect of intensive
patient education on the secondary outcome of disability at 1 week (mean difference, –1.6
points on a 24-point scale [95% CI, –3.1 to –0.1]) and 3months (mean difference, –1.7 points,
[95% CI, –3.2 to –0.2]) but not at 6 or 12 months.
CONCLUSIONS AND RELEVANCE Adding 2 hours of patient education to recommended
first-line care for patients with acute low back pain did not improve pain outcomes. Clinical
guideline recommendations to provide complex and intensive support to high-risk patients
with acute low back pain may have been premature.
TRIAL REGISTRATION Australian Clinical Trial Registration Number: 12612001180808
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F or the past 5 years, the Global Burden of Disease Study1has consistently ranked low back pain as the leadingcause of disability worldwide. Low back pain is second
only to the common cold as a reason for consulting a general
practitioner.2Arecent international reviewhighlightedaglobal
crisis in themismanagement of lowbackpain,withhigh rates
of guideline-discordant care in both high- and low-middle in-
come countries.3-5 In their call to action, the Lancet LowBack
Pain Series Working Group authors recommended that re-
searchers and policy makers: “Develop and implement strat-
egies to ensure early identification andadequate educationof
patients with low back pain at risk for persistence of pain and
disability.”3-5
Tomanageuncomplicatedacute lowbackpain (fewer than
6 weeks of pain duration), international guidelines recom-
mend that general practitionersprovideadvice, education, re-
assurance,andsimpleanalgesics, ifnecessary.6Althoughmany
patients receiving this care improve rapidly, 33% experience
a recurrence in the next 12months7 and 20% to 30% develop
chronic pain (defined as pain duration of 3months ormore).8
Patientswhoare at high risk of pain chronicitymay require
additional care, including second-line options such as physical
(eg,spinalmanipulation)and/orpsychological therapies(eg,psy-
chologically informedphysiotherapy).6However,mosttrialsthat
haveevaluatedaddingsecond-linetreatmentoptionstostandard
guideline care for patientswith acute lowbackpainhave failed
todemonstrate effectiveness comparedwithplacebo (eg, addi-
tionofspinalmanipulation,nonsteroidalantiinflammatorydrugs,
orboth9;additionofstructuredexercises10;andadditionofacu-
puncture,massage, or chiropractic care11). Patient education, a
treatment that authors of a 2008Cochrane review12 concluded
was effective for acute lowbackpainwhen applied in an inten-
sive formatandthateverymajorclinicalguidelinerecommends
(butwith little instructionon intensity),13hasneverbeentested
in aplacebo-controlled trial. Anybenefits observed inprevious
trials of patient education for acute low back pain could be ex-
plainedbynonspecificeffectsoftheclinicalencounterorthechar-
acteristics of the usual care comparison.
Pain education, a form of intensive patient education that
is often included inpainmanagementprograms, requiresup to
2 hours during several encounterswith a trained health practi-
tioner. It involvesdetaileddiscussionofpain, includingpsycho-
social contributors and advice about pacing and activity. Trials
have found clinically meaningful effects of pain education on
pain and disability in samples of patients with chronic pain.14
It isunknownwhether intensivepatienteducation, inaddi-
tion to recommended first-line care, can improveoutcomes for
patientswith acute lowbackpain. Toaddress this gap in the lit-
erature,weconducted, toourknowledge, the first randomized,
placebo-controlled trial of patient education for acute lowback
pain (Preventing Chronic LowBack Pain [PREVENT] Trial).15
Methods
Study Design
Thiswas an assessor-blinded, 1:1 parallel group, randomized,
placebo-controlled trial. We published a study protocol prior
to enrolling participants15 (the original trial protocol is avail-
able in Supplement 1). The trial was prospectively registered.
The University of New South Wales Human Research Ethics
Committee, Sydney,NewSouthWales,Australia, approved the
study on February 5, 2013 (reference number: HC12664). We
obtained written, informed consent from all participants be-
fore they enrolled in the trial.
Treatments took place at physiotherapy clinics, general
practices, or clinic rooms at a research institute (Neurosci-
enceResearchAustralia) in Sydney,Australia.Oneof 2 trial cli-
nicians (A.C.T. and I.W.S.) provided the treatment at partici-
pating centers.We recruitedparticipants betweenSeptember
10, 2013, and December 2, 2015. Trial follow-up was com-
pleted on December 17, 2016.
Participants
Wesought to recruit participants aged 18 to 75yearswhowere
seeking care for acute low back pain with or without referred
legpain. Participantswith signsof radiculopathy (spinal nerve
root compromise) were included. All participants were re-
ferred from general practitioners or physiotherapists. We ex-
cluded potential participants if they had the following: (1)
chronic low back pain (more than 1 on a 11-point pain inten-
sitynumeric rating scale formore than3months), (2) less than
3of 10on thepain intensity numeric rating scale over thepast
week, (3) low risk of pain chronicity (less than 30% absolute
risk of chronic pain according to the Predicting Inception of
Chronic Pain (PICKUP) Tool8 [eMethods 1 in Supplement 2]),
(4) clinical features of serious spinal pathology (eg, cauda
equina syndrome, infection, fracture, or cancer) assessed by
a clinician, (5) poor commandof theEnglish language, (6) pre-
viousspinal surgery,or (7)amentalhealthconditionthatwould
preclude studyparticipation.Referring clinicianswere trained
toprovide all recruitedparticipantswith guideline-based care
(advice to stay active, avoidbed rest, optionof spinalmanipu-
lation,and/orsimpleanalgesics).Staffwerereimbursedperpar-
ticipant recruited for time spent on the study.
Randomization andMasking
Werandomizedparticipants ina 1:1 ratio toeither intensivepa-
tient education or placebo patient education. The allocation
schedule was generated by a researcher not involved in any
other aspect of the study. That researcher used a computer-
ized random number table to generate the allocation se-
quence in random block sizes of 4, 6, 8, and 10. The same re-
Key Points
Question Is intensive patient education effective as part of
first-line care for patients with acute low back pain?
Findings In this randomized clinical trial of 202 adults with acute
low back pain from Sydney, Australia, adding intensive patient
education to first-line care of patients was no better at improving
pain outcomes than a placebo intervention.
Meaning Intensive patient education should not be offered to
patients with acute low back pain who are receiving first-line care.
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searcher who generated the allocation sequence placed
allocation codes into sequentially numbered, sealed, opaque
envelopes.
Before randomization, all participants completed base-
line data collection and received a standardized short history
and physical examination (approximately 10-minute length)
with the trial clinicians (A.C.T. and I.W.S.). The short history
andphysical examinationwere standardizedusing pro forma
documents (eMethods 2 in Supplement 2). The trial clini-
ciansopenedtheenvelopecontaining thegroupallocation.The
allocation was concealed from participants, referring clini-
cians, other trial staff, and outcome assessors.
Alltreatmentwasprovidedduringtheacutephaseoflowback
painwithin6weeksofpainonset.Eachparticipant received2 ×
1–hour individual, face-to-facesessionsofeitherpatienteduca-
tionorplacebopatienteducation.Thetrial clinicians (A.C.T.and
I.W.S.)whoprovidedthepatienteducationsessionswerethesame
clinicianswhoprovidedtheplacebopatienteducation.Anexpert
inpaineducation (G.L.M.) trainedboth trial clinicians todeliver
thepatienteducation intervention.Anexpert clinicalpsycholo-
gist inpainmanagement (M.K.N.) trainedboth trial clinicians in
theplacebopatienteducation intervention.Training for thepa-
tienteducation intervention tookapproximately 16hours,with
6to8hoursallocatedforpracticingrole-playscenarios.Training
fortheplacebopatienteducationtookapproximately4hoursand
wassupplementedwith4online45-minutevideosdemonstrat-
ing techniques forprovidingacredibleconsultationthatdidnot
include advice or education.
Interventions
Intensive Patient Education
We adapted the information and advice provided in the pa-
tienteducationgroup fromthebookExplainPain,16 a text typi-
callyused forpeoplewith chronicpain.The intervention isde-
scribed in full and according to the template for intervention
description and replication (TIDieR) checklist in eMethods 3
in Supplement 2. In short, participants in the patient educa-
tion group were provided with a detailed explanation about
the biopsychosocial nature of pain in the format of diagrams,
metaphors, andstories.Thepatient education intervention in-
volved 3 main components: (1) reframing unhelpful beliefs
about lowbackpain, (2) presenting informationabout thebio-
logic basis andprotectivenatureof bothacute andchronic low
back pain, and (3) evaluating understanding of new concepts
and discussing techniques to promote recovery. Content was
tailored to the individual according to specific concerns (eg,
“I am worried I will have this back problem forever”) and
misconceptions (eg, “I can’t work becausemy back is perma-
nently damaged”) that participants expressedduring the con-
sultation. Trial clinicians encouraged all participants to self-
manage their low back pain by remaining active and avoiding
bed rest. Trial clinicians also instructed participants on be-
havioral therapy techniques such as pacing.
Placebo Patient Education
We designed the placebo patient education sessions to con-
trol for time with an expert clinician. The sessions mimicked
all aspects of the patient education sessions (listening, show-
ing interest, andattentionof theclinician)butwithout theedu-
cation component. Participants in the placebo patient educa-
tiongroupreceivedno information, advice,oreducationabout
low back pain from the trial clinician. Participants were en-
couraged to talk about any topic that they desired. Trial clini-
cian responseswere aimed tomaintain the discussion for the
duration of the session. We included additional detail on the
placebo intervention in eMethods 4 in Supplement 2.
Outcomes andMeasurements
Wecollectedself-reporteddatafromparticipantsatbaseline(the
first interventionsession);1weekafterthe2interventionsessions
werecomplete;and3,6,and12monthsafter thedateof lowback
painonset.Participantsusedonline formstocompleteoutcome
assessments.Baselinedataincludedage,sex,durationofepisode,
numberofpreviousepisodes,otherpainfulareas, andworksta-
tus.Anassessorwhowasmaskedtotreatmentallocationarranged
the collectionof outcomedatausing online forms. Participants
completedthecredibilityandexpectancyquestionnaire17 inpa-
per format immediately after the trial clinician explained the
rationaleforthestudyandbeforerandomization.Trialstaffmoni-
toredadherenceto the2 interventionsessionsusingastudycal-
endar.Thetrialclinicianaudiorecordedall interventionsessions,
withtheparticipants’verbalconsent, tomonitortreatmentfidel-
ity.Treatmentfidelitywasevaluatedby2researchers(G.L.M.and
M.K.N.),wholistenedtothefirstandsecondsessionsfrom10ran-
domlyselectedparticipantsandjudgedwhetherthesessionswere
patienteducationorplacebopatienteducation.Weusedκtode-
termine agreement.
Theprimary outcomewasmeanpain intensity during the
pastweek (reportedon an 11-point pain intensity numeric rat-
ing scale), assessed 3months after the onset of lowback pain.
Secondary outcomes and process measures are described in
eMethods 5 of Supplement 2.
Statistical Analysis
Wepublished our statistical analysis plan before analyzing our
results.18 A sample of 202 participants was required to ensure
80%power todetect ameandifferenceof 1pointonan 11-point
numeric ratingscale forpain intensity.Ourpowercalculationas-
sumedanSDof2.3anda2-sidedαof .05andwasadjustedwith
15% loss to follow-up.We estimated the effect of the interven-
tionon theprimary outcomeusing amixedmodel for repeated
measures.We treated timeas a categorical variable (1weekand
3,6,or 12months)and includedgroup × timeinteractions tode-
termine treatment effects at each timepoint. As anexploratory
sensitivity analysis,we calculatedPvalues frommixedmodels
forrepeatedmeasurescomparingbetween-groupdifferencedur-
ing the full 12-month trial, controlling for baseline and includ-
ing all timepoints as categorical.Wedetermined statistical sig-
nificancetobeP < .05fora2-sidedtest.Wedidnot includestudy
site (physiotherapypractice, general practice, or research insti-
tute) in themodel because therewas no evidence of site differ-
encesbetweengroups (χ2 test,P = .14).Detailsof theanalysisof
secondary outcomes is provided in eMethods 5 of Supplement
2 and the complete mediation analysis19 in eResults 1 of
Supplement 2. Two authors (S.L. and H.L.) performed the sta-
tistical analyses.
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Results
Between September 10, 2013, and December 2, 2015, we
screened 618 potential participants. Figure 1 shows the flow
of participants through the trial. Themain reasons for partici-
pant exclusion included low risk of pain chronicity (n = 146),
chronic pain (n = 79), declinedparticipation (n = 75), or could
notbecontactedafter initial referral fromtheprimarycareprac-
titioner (n = 75). Other reasons for exclusion are shown in
Figure 1. One potential participant was excluded in error be-
cause of pregnancy.
The 2 groups had similar demographic and clinical char-
acteristics at baseline (Table 1). Of 202 participants random-
ized for the trial, 103 (51.0%) were female. Participants were
middle-aged (mean [SD] age, 45.1 [14.5] years), had fewer than
2weeksof lowbackpain, andhadexperienced3previous epi-
sodes of low back pain. Physiotherapists referred most par-
ticipants (83%).Half of the sample (52%) felt therewas aneed
for further investigationof their symptoms.Psychological char-
acteristics were similar between groups; scores for depres-
sion and catastrophizing scaleswere lower and scores for self-
efficacywerehigher than those seen in samples frompatients
with chronic pain who attended tertiary care.20
All participants completed both trial sessions. Treatment
credibilityscoreswerenotdifferentbetweengroups (mean[SD]
credibilityandexpectancyquestionnaire score forpatientedu-
cation vs placebo patient education: 36.6 [8.8] vs 35.3 [10.5];
mean difference, –1.3; 95% CI, –4.0 to 1.4). For our treatment
fidelity check, raters correctly categorizedall recordings aspa-
tient education or placebo patient education. There was per-
fect agreement between raters (κ = 1).
The primary analysis (Table 2) showed that patient edu-
cationwas notmore effective than placebo patient education
at reducing pain intensity at our primary end point (3-month
follow-up mean difference, –0.3 points on an 11-point scale;
95% CI, –1.0 to 0.3; P = .31). Mean (SD) pain intensity de-
creased from6.3 [2.4] at baseline to 2.1 [2.4] at 3months in the
patient education group and from 6.1 [2.2] at baseline to 2.4
[2.2] at 3 months in the placebo patient education group.
(Figure 2).
There was a small effect of treatment group on disability,
with patient education lower than placebo patient education
at 1 week (mean difference, –1.6 points on a 24-point scale;
Figure 1. Flowchart of the Preventing Chronic LowBack Pain (PREVENT) Randomized Placebo-Controlled Trial
618 Participants referred from primary care
practitioners and assessed for eligibility
416 Excluded
266 Did not meet inclusion criteria
146 Low risk of pain chronicity
79 Persistent pain
18 Low pain intensity (<3/10)
7 Pain duration >6 wk
6 Previous spinal surgery
5 Age <18 or >75 y
4 Primary pain not in low back
1 Pregnancy
150 Other reasons
75 Could not be contacted
75 Declined
202 Randomized
101 Allocated to two 1-h treatments with patient
education
101 Allocated to two 1-h treatments with placebo
patient education
98 Completed 1-wk follow-up
3 Lost to follow-up (lost contact)
96 Completed 1-wk follow-up
5 Lost to follow-up (lost contact)
97 Completed 3-mo follow-up
4 Lost to follow-up (lost contact)
97 Completed 3-mo follow-up
4 Lost to follow-up (lost contact)
96 Completed 6-mo follow-up
5 Lost to follow-up (lost contact)
95 Completed 6-mo follow-up
6 Lost to follow-up (lost contact)
94 Completed 12-mo follow-up
7 Lost to follow-up (lost contact)
89 Completed 12-mo follow-up
12 Lost to follow-up (lost contact)
101 Included in primary analysis 101 Included in primary analysis
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Table 1. Baseline Characteristicsa
Characteristic Patient Education (n = 101) Placebo Patient Education (n = 101)
Age, mean (SD), y 46.5 (14.7) 43.8 (14.1)
Female sex 53 (52.5) 50 (49.5)
Clinical characteristic
Pain duration, mean (SD), d 12.5 (7.7) 13.5 (8.7)
No. of previous episodes, median (IQR) 3 (5) 3 (7)
No. of other pain sites, mean (SD) 1.0 (1.2) 1.1 (1.3)
Referred by general practitioner 19 (18.8) 16 (15.8)
Referred by physiotherapist 82 (81.2) 85 (84.2)
First episode of back pain 21 (20.8) 18 (17.8)
Pain referred to leg 47 (46.5) 57 (56.4)
Pain in areas other than back or leg 57 (56.4) 55 (54.5)
Work absence or reduced hours 22 (21.8) 31 (30.7)
Receiving pain medication 50 (49.5) 54 (53.5)
Outcome scores at baseline
Pain intensity, mean (SD)b
Week 6.3 (2.4) 6.1 (2.2)
Current 4.0 (2.2) 4.0 (2.3)
Pain interference, mean (SD)c 6.0 (2.5) 6.4 (2.6)
Disability, mean (SD)d 11.0 (5.4) 11.7 (5.8)
Depressive symptoms, mean (SD)e 4.1 (3.7) 5.1 (5.0)
Reassurance
Nothing seriously wrong, mean (SD)f 5.6 (2.7) 5.4 (2.7)
Yes, perceive a need for further tests 51 (50.5) 55 (54.5)
Process measures at baseline, mean (SD)
Neuroscience knowledgeg 6.0 (1.8) 5.9 (1.6)
Pain attitudes: pain is sign of damageh 2.3 (1.2) 2.5 (1.1)
Pain self-efficacyi 35.5 (13.1) 33.1 (13.0)
Catastrophizingj 18.3 (12.0) 19.9 (11.2)
Back beliefsk 27.7 (6.8) 28.3 (6.4)
Abbreviation: IQR, interquartile range.
a Data are presented as number (percentage) of patients unless otherwise
indicated.
bNumeric rating scale with range from0 (no pain) to 10 (worst pain possible).
c Numeric rating scale with range from0 (no interference) to 10 (highest
interference possible).
d RolandMorris Disability Questionnaire with range from0 (no disability) to 24
(high disability).
e Depression severity scale of Depression, Anxiety and Stress Scale with range
from0 (no depressive symptoms) to 42 (high depressive symptoms).
f“How reassured do you feel that there is no serious condition causing your back
pain?” Range from0 (not reassured at all) to 10 (completely reassured).
g Neurophysiology of Pain Questionnaire with range from0 (no knowledge) to
19 (highest knowledge).
h Survey of Pain Attitudes, question 3 from 1-item version: “The pain I feel is a
sign that damage is being done.” Range from0 (very untrue for me) to 4 (very
true for me).
i Pain Self-Efficacy Questionnaire with range from0 (low pain self-efficacy) to
60 (high pain self-efficacy).
j Pain Catastrophizing Scale with range from0 (low catastrophizing) to 52 (high
catastrophizing).
k Back Beliefs Questionnaire with range from 9 (maladaptive or pessimistic
beliefs) to 45 (helpful or positive beliefs).
Table 2. Primary Outcomes for the Patient Education and Placebo Patient Education Groups at 1Week
and 3, 6, and 12Months
Variable
Point Estimates, Mean (SD)
Mean Difference
(95% CI) P ValuePatient Education
Placebo Patient
Education
Pain intensity during the
past week
1 wk 3.2 (2.4) 3.1 (2.2) 0.1 (−0.5 to 0.8) .69
3 mo 2.1 (2.4) 2.4 (2.2) −0.3 (−1.0 to 0.3) .31
6 mo 2.3 (2.6) 2.5 (2.3) −0.2 (−0.8 to 0.5) .59
12 mo 1.8 (2.2) 2.5 (2.4) −0.6 (−1.3 to 0.1) .07
Overall intervention
effecta
NA NA NA .26
Abbreviation: NA, not applicable.
a P value is frommixedmodels for
repeatedmeasures comparing
between-group difference during
the full 12-month trial, controlling
for baseline and including time
points as a categorical variable.
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95% CI, –3.1 to –0.1; P = .03) and at 3 months (mean differ-
ence, –1.7 points; 95%CI, –3.2 to –0.2;P = .03) (Table 3). There
were no between-group differences in disability at 6- or 12-
month follow-up.
There were some significant between-group differences
in secondary outcomes (Table 3). The odds of having a recur-
rence of low back pain at 12months were lower in the patient
education group than in the placebo patient education group
(odds ratio,0.44;95%CI,0.24-0.82). Pain interferenceand the
oddsof seekinghealth carewere also lower in thepatient edu-
cation group at 3 months (pain interference: mean differ-
ence, –0.8; 95% CI, –1.5 to –0.1; P = .02; health care seeking:
odds ratio, 0.43; 95%CI, 0.19-0.93), but results for these vari-
ables were not lower at 6 or 12months. Pain attitudes and re-
assuranceat 1weekwerehigher in thepatient educationgroup
(pain attitudes: mean difference, –0.9; 95% CI, –1.2 to –0.5;
P < .001; reassurance [“How reassured do you feel that there
is no serious condition causing your back pain?”]: mean dif-
ference, 1.2; 95%CI, 0.4-2.0;P = .003), and the effect on pain
attitudes persisted at 12 months.
Patient educationwasnotmoreeffective thanplacebopa-
tient education for reducing depressive symptoms, the inci-
dence of chronic low back pain, or global perceived change
(Table 3). The causal mediation analysis confirmed that pa-
tient education reduced catastrophizing and unhelpful be-
liefs (primary treatment targets), but thesepsychologicmecha-
nisms did not reduce pain intensity (full results of mediation
analysis reported in eResults 1, eTables 1 and 2, and eFigures
1-3 in Supplement 2). There were no reported adverse events
in either treatment group. Therewasno evidence that out-of-
trial therapy confounded treatment effects (eResults 2 and
eTable 2 in Supplement 2).
Discussion
Our study provides evidence that intensive patient educa-
tion is not effective compared with placebo for patients with
acute low back pain. Two 1-hour sessions of patient educa-
tionwerenomoreeffective thanaplacebo intervention for im-
provingpainat ourprimaryendpoint of 3monthsor at 1week,
6months, or 12months after the onset of acute lowbackpain.
Disability was significantly lower in the intervention group
comparedwith the placebo group at 1week and 3months but
not at 6 months or 12 months. The short-term effects on dis-
ability, although consistent with those from similar trials,21
were below published guidance on clinically meaningful ef-
fects (2 points on a 24-point Roland Morris Disability Ques-
tionnaire and 1pointona 10-pointnumeric rating scale).22Our
results suggest that offering more intensive patient educa-
tion to patients with acute low back pain than that provided
as part of standard practice does not reduce pain intensity or
lead to meaningful reductions in disability.
Our results challengeawidespreadbelief thatpatient edu-
cation is an effective strategy for treatment of acute low back
pain. For example, every clinical guideline recommends pa-
tient education to manage acute low back pain.13 These rec-
ommendations are, however, oftenunaccompaniedbyanevi-
dence statement (eg, neither US23 nor UK22 guidelines cite
evidence for patient education) or instruction onhowpatient
education interventions shouldbe conducted.24 Two system-
atic reviews have concluded that primary care–based patient
education is effective for acute low back pain.12,25 The avail-
able Cochrane review12 of individual patient education in-
cluded6 trials of patient education comparedwithusual care:
3 trials of brief interventions (<20minutes) and 3 trials of in-
tensive interventions (>2 hours). The authors concluded that
intensive patient educationmay bemore effective at increas-
ing return-to-work rates compared with usual care based on
2 trials (n = 1432). However, those trials did not include pain
or disability outcomes. Although a more recent review of 14
trials foundthatbriefpatienteducationcouldreducebackpain–
related distress (n = 4872),25 it was unclear whether these in-
terventions could improve other clinical outcomes such as
pain.26 Of importance, our mediation analysis (eResults 1 in
Supplement 2) suggests that interventions aimed at reducing
pain-relateddistress (eg, catastrophization) areunlikely to in-
fluence the pain experience as much as previously thought.
Strengths and Limitations
This trial15 had several strengths. It was the first trial, to our
knowledge, to test a patient education intervention against a
credible placebo (ie, a professional consultation without any
information or advice) in patients with acute low back pain.
Figure 2. Treatment Effects of Intensive Patient Education on Pain and Disability
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outcomes score at 1 week and 3, 6,
and 12months using the Roland
Morris Disability Questionnaire
ranging from0 (no disability) to 24
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This strategy allowed us to determine the specific effects of
patient education and control for effects produced by a clini-
cal encounter, for example, those fromtheattentionofahealth
professional or from the credibility of an impending treat-
ment. We trained 2 trial clinicians to ensure treatment fidel-
ity.Retention rateswerehigh (>90%at all timepoints).We fol-
lowedapublishedtrialprotocol15 andstatistical analysisplan.18
Data were collected and analyzed by researchers who were
masked to group allocation.
We used PICKUP, a validated prognosis model,8 to ex-
cludepeoplewith acute lowbackpainwhowere at lower than
average risk of pain chronicity. Approximately 40% of in-
cluded participants developed chronic low back pain, a rate
twice that of other trials on acute low back pain conducted in
the same geographical area of Sydney (approximately
15%-20%).9,27Weare thereforeconfident thatwe includedpar-
ticipants who were at high risk of pain chronicity.
This study alsohas limitations. First, trial clinicians could
notbeblinded to treatment allocation.However, results of our
audit suggested that there were no systematic differences in
treatment credibility or treatment fidelity. Second, interven-
tions in the PREVENT trial15 were provided by trial physio-
therapists, and it is unclear whether our results would have
been the same if the participant’s health practitioner pro-
vided the intervention. Third,we performed a number of sta-
tistical comparisons, which although planned, increased the
Table 3. Secondary Outcomes for the Patient Education and Placebo Patient Education Groups at 1Week
and 3, 6, and 12Monthsa
Variable
Patient
Education
Placebo Patient
Education
Effect Measure Mean
Difference or OR (95% CI) P Value
Chronic low back pain at 3 mo,
No./total No. (%)b
33/96 (34.4) 42/93 (45.1) 0.63 (0.32 to 1.14) .13
Disabilityc
1 wk 5.6 (5.2) 7.1 (5.8) −1.6 (−3.1 to −0.1) .03
3 mo 3.5 (4.6) 4.9 (6.0) −1.7 (−3.2 to −0.2) .03
6 mo 3.8 (5.2) 4.3 (5.2) −0.8 (−2.4 to 0.7) .28
12 mo 3.0 (4.7) 3.8 (5.1) −0.8 (−2.4 to 0.7) .29
Overall intervention effectd NA NA NA .17
Pain interferencee
1 wk 2.8 (2.7) 2.9 (2.5) −0.1 (−0.8 to 0.6) .71
3 mo 1.5 (2.1) 2.3 (2.4) −0.8 (−1.5 to −0.1) .02
6 mo 1.8 (2.6) 1.9 (2.3) −0.1 (−0.8 to 0.6) .87
12 mo 1.6 (2.4) 2.0 (2.5) −0.4 (−1.1 to 0.3) .30
Overall intervention effectd NA NA NA .16
Depressive symptomsf
1 wk 2.6 (4.1) 3.3 (4.3) −0.7 (−1.8 to 0.5) .26
3 mo 2.1 (3.9) 2.5 (4.1) −0.5 (−1.7 to 0.6) .36
Overall intervention effectd NA NA NA .89
Current pain intensityg
1 wk 2.3 (2.1) 2.2 (2.1) 0.1 (−0.5 to 0.7) .69
3 mo 1.5 (2.0) 2.1 (2.1) −0.6 (−1.2 to −0) .04
6 mo 1.8 (2.5) 1.8 (1.9) −0.1 (−0.7 to 0.5) .78
12 mo 1.4 (2.1) 1.7 (2.1) −0.3 (−0.9 to 0.3) .33
Overall intervention effectd NA NA NA .13
Seeking health care for low back
pain, No./total No. (%)
3 mo 73/96 (76.0) 82/93 (88.2) 0.43 (0.19 to 0.93) .03
6 mo 44/95 (46.3) 48/91 (52.7) 0.77 (0.43 to 1.38) .38
12 mo 32/91 (35.2) 38/87 (43.7) 0.70 (0.38 to 1.28) .25
Global change at 3 moh 8.1 (1.7) 7.8 (2.0) −0.3 (−0.9 to 0.2) .11
Recurrence at 12 mo, No./
total No. (%)i
26/91 (28.6) 41/87 (47.1) 0.44 (0.24 to 0.82) .01
Pain attitudes
1 wk 1.3 (1.2) 2.2 (1.3) −0.9 (−1.2 to −0.5) <.001
12 mo 1.2 (1.2) 1.6 (1.3) −0.4 (−0.7 to 0) .03
Overall intervention effectd NA NA NA .16
Nothing seriously wrong
(0-10) at 1 wkj
7.6 (2.5) 6.5 (2.9) 1.2 (0.4 to 2.0) .003
Yes, perceive a need for
further tests at 1 wk, No./total
No. (%)
25/98 (25.5) 36/96 (37.5) 0.57 (0.31 to 1.05) .07
Abbreviations: NA, not applicable;
OR, odds ratio.
a Data are presented as mean (SD)
unless otherwise indicated.
bReporting 2 or more on an 11-point
pain intensity numeric rating scale
during the past week and no periods
of recovery at that time.
c RolandMorris Disability
Questionnaire with range from0
(no disability) to 24 (high disability).
dP value is frommixedmodels for
repeatedmeasures comparing
between-group difference during
the full 12-month trial, controlling
for baseline and including time
points as a categorical variable.
e Numeric rating scale with range
from0 (no interference) to 10
(highest interference possible).
f Depression severity scale of
Depression, Anxiety, and Stress
Scale with range from0 (no
depressive symptoms) to 42 (high
depressive symptoms).
g Numeric rating scale with range
from0 (no pain) to 10 (worst pain
possible).
h Global Back Recovery Scale.
i Recurrence was defined as
answering yes to both of the
following questions: (1) “In the last 6
months/12 months, has your lower
back pain gone away completely for
a period of more than 30 days, only
to return later on?” and (2) “If yes,
did the return of low back pain last
at least 24 hours with a pain
intensity of more than 2/10?”
j “How reassured do you feel that
there is no serious condition causing
your back pain?” Range from0 (not
reassured at all) to 10 (completely
reassured).
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risk of Type I error. Interpretation of the statistically signifi-
cant effects of intensive patient education on some second-
ary outcomes, such as pain interference and recurrence and
odds of seeking health care (Table 3), must consider this po-
tential limitation. Finally, because both groups received ba-
sic patient education as part of recommended first-line care
andmany recovereddespitebeing classifiedasbeinghigh risk,
the potential for between-group differences may have been
reduced.
Conclusions
For patients with acute low back pain who received first-line
care, intensive patient education was no more effective
than a placebo intervention. Adding complex, time-
consuming treatments to primary-care based advice and
reassurance is likely to be unnecessary for most patients
with acute low back pain.
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